• Протек
    LEADERSHIP
    THROUGH PARTNERSHIP
  • Протек 2
    LEADERSHIP
    THROUGH PARTNERSHIP
  • Протек 4
    LEADERSHIP
    THROUGH PARTNERSHIP

ZdravCity has become a partner of Mail.Ru Group as part of the new online service for searching and ordering medicines

Online service ZdravCity (project of CV PROTEK) has become one of the partners of online service for searching and ordering medicines “All pharmacies”, which started on 10 April.

Assortment of ZdravCity includes about 10 thousand items of medical products and goods for beauty and health. Their number ranges depending on the region where the user is located.

Comfortable search allows quickly finding necessary goods. While choosing the medical product you can choose form of presentation and necessary dosage, get acquainted with the product’s analogues and compare their cost. The product cards show the product’s detailed description and instruction for use, indications and counterindications.

You can take your order in the nearest pharmacy - pharmacies within the settlement will be shown on the map and in the form of a list. The project includes 14 thousand ZdravCity pharmacies in 78 regions of the Russian Federation.

In the future the project plans to offer to the users a possibility to choose a pharmacy from among those pharmacies where the required product is available, so that they could take their order within several hours.

As well, mobile applications “All pharmacies” will be developed for IOS and Android.

The First ZdravCity Pharmacy Opened on MCC

The pharmacy’s main function is servicing of customers making orders via online-service (more...

Online service ZdravCity started delivering cosmetics and parapharmaceuticals

The new option covers 5.5 thousand items, including cosmetics (more than 3 thousand), parapharmaceuticals (1.2 ... more...

The New Life program of Protek Charity Fund received the I Russian National Award “Face of the Nation”

The winner's certificate was handed to the Director General of Protek Mr. Nikolai Polianskii.  more...